Texas House Bill HB2087

Texas 2019 - 86th Regular

Caption

Relating to Schedule II controlled substance prescriptions under the Texas Controlled Substances Act.

Impact

If enacted, HB2087 would significantly align state law with current best practices in prescription management for controlled substances. The requirement for electronic prescriptions is expected to streamline the prescribing process, improve accuracy in medication dispensation, and contribute to the fight against prescription drug abuse by ensuring tighter control over the issuance of these substances. The bill is positioned to impact both prescribers and dispensers by mandating compliance with new prescribed procedures and digital documentation.

Summary

House Bill 2087 addresses the regulation of Schedule II controlled substances under the Texas Controlled Substances Act. The bill proposes that prescriptions for these controlled substances must be issued electronically, eliminating the option for written, oral, or telephonic prescriptions, except in emergencies as defined by the associated board rules. This legislative change aims to modernize the prescription process, enhance tracking, and reduce potential misuse of these potent medications.

Contention

Debate surrounding HB2087 may revolve around concerns regarding accessibility and the efficacy of emergency exemptions. Critics might argue that requiring electronic prescriptions could pose burdens for prescribers in rural areas with limited internet access, potentially hindering patients from receiving timely care. Moreover, issues surrounding data privacy and the security of electronic prescription systems could raise additional questions. The balance between enhancing prescription control and ensuring patient access and safety is likely to be a focal point of discussion as the bill progresses through the legislative process.